Does the triglyceride glucose (TyG) index have diagnostic and prognostic value for medical conditions related to insulin resistance and metabolic disorders?
The TyG index shows promise as a biomarker for screening and predicting conditions related to insulin resistance, but current evidence is limited by study heterogeneity and methodological quality.
The TyG index is a promising biomarker for screening and predicting various medical conditions, particularly those related to insulin resistance and metabolic disorders. However, the heterogeneity and methodological quality of the included studies suggest the need for further high-quality research to confirm these findings and refine the clinical utility of the TyG index.
Nayak et al. (Fri,) studied this question.